<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04541147</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00103025</org_study_id>
    <nct_id>NCT04541147</nct_id>
  </id_info>
  <brief_title>Opioid &amp; Steroid Use Following Tonsillectomy in Pediatric Patients</brief_title>
  <official_title>A Randomized Control Trial of Post-operative Course of Oral Dexamethasone and Effect on Opioid Usage in Pediatric Tonsillectomies in a Tertiary Care Center</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if a post-operative course of oral dexamethasone&#xD;
      affects opioid usage in pediatric patients undergoing tonsillectomy.&#xD;
&#xD;
      Patients who are scheduled to undergo tonsillectomy or adenotonsillectomy are randomized to&#xD;
      receive either 1) a post-operative steroid course of oral dexamethasone in addition opioids,&#xD;
      acetaminophen,NSAIDs or 2) opioids/acetaminophen/NSAIDS alone. All drugs are prescribed per&#xD;
      approved FDA labeling. Children between the ages of 4-17 will be considered for enrollment.&#xD;
&#xD;
      Participants (or with the aid of parents/legal guardian for subjects unable to complete on&#xD;
      their own) will complete a diary twice a day to record pain medication administration and&#xD;
      visual pain scale. Remaining steroid and opioid medication will be measured at the routine&#xD;
      post-operative appointment that occurs 4 - 6 weeks following surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">April 14, 2021</start_date>
  <completion_date type="Anticipated">July 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 30, 2022</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Opioid use</measure>
    <time_frame>4 weeks post-op</time_frame>
    <description>measured by medication log and units remaining</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in pain score</measure>
    <time_frame>twice daily from surgery to 14 days post-op</time_frame>
    <description>measured by a visual analog scale, where 0 is no pain and 10 is worst possible pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of post-operative complications</measure>
    <time_frame>30 days post-op</time_frame>
    <description>Measured by post-op re-admissions and emergency room visits</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Dexamethasone plus analgesics</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>oral dexamethasone of 0.5mg/kg/day (max of 8mg/day), administered on post-operative days 1,3,5,7 in addition to standardized course of analgesics (opioids/acetaminophen/NSAIDs).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>analgesics alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>standardized course of analgesics (opioids/acetaminophen/NSAIDs)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>dexamethasone solution or tablet (depending on age of patient) at 0.5mg/kg/day max of 8mg/day, administered on post-operative days 1,3,5,7.</description>
    <arm_group_label>Dexamethasone plus analgesics</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Analgesics</intervention_name>
    <description>standardization of post-operative analgesics (narcotics and non-narcotic medication).&#xD;
Oxycodone solution or tablet (depending on age of patient) at 0.05-0.1 mg/kg/dose every 6hrs; max 5mg (obese/OSA); prescribe 30 doses&#xD;
Acetaminophen 10-15 mg/kg/dose every 6 hours; max 500mg per dose; prescribe 56 doses (over the counter medication)&#xD;
Ibuprofen 5-10 mg/kg/dose every 6 hours; max 200 mg/dose; prescribe 56 doses (over the counter medication)</description>
    <arm_group_label>Dexamethasone plus analgesics</arm_group_label>
    <arm_group_label>analgesics alone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 4-17 years at time of surgery&#xD;
&#xD;
          -  Scheduled for tonsillectomy or adenotonsillectomy surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Prior history of intracapsular tonsillectomy&#xD;
&#xD;
          -  Previous diagnoses of Down Syndrome or developmental delay&#xD;
&#xD;
          -  Presence of gastrostomy (g) tube&#xD;
&#xD;
          -  A contraindication to steroids or steroid usage within 30 days prior to surgery&#xD;
             including diabetes, allergy to steroid, already on chronic steroid, immune deficiency&#xD;
&#xD;
          -  Active infection or concurrent operative procedures at the time of surgery&#xD;
&#xD;
          -  Unable to read or speak English&#xD;
&#xD;
          -  Pregnant or breastfeeding females&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eileen Raynor, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Duke University Medical Center and affiliated practices</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>September 1, 2020</study_first_submitted>
  <study_first_submitted_qc>September 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 9, 2020</study_first_posted>
  <last_update_submitted>July 2, 2021</last_update_submitted>
  <last_update_submitted_qc>July 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

